- Home
- ATXS vs SMC Comparison
ATXS vs SMC Comparison
Compare ATXS & SMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- SMC
- Stock Information
- Founded
- ATXS 2008
- SMC 2009
- Country
- ATXS United States
- SMC United States
- Employees
- ATXS N/A
- SMC N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- SMC
- Sector
- ATXS Health Care
- SMC
- Exchange
- ATXS Nasdaq
- SMC NYSE
- Market Cap
- ATXS 401.2M
- SMC 363.3M
- IPO Year
- ATXS 2015
- SMC 2012
- Fundamental
- Price
- ATXS $4.48
- SMC $28.20
- Analyst Decision
- ATXS Strong Buy
- SMC
- Analyst Count
- ATXS 6
- SMC 0
- Target Price
- ATXS $30.00
- SMC N/A
- AVG Volume (30 Days)
- ATXS 501.6K
- SMC 74.2K
- Earning Date
- ATXS 05-20-2025
- SMC 05-07-2025
- Dividend Yield
- ATXS N/A
- SMC N/A
- EPS Growth
- ATXS N/A
- SMC N/A
- EPS
- ATXS N/A
- SMC N/A
- Revenue
- ATXS N/A
- SMC $444,383,000.00
- Revenue This Year
- ATXS N/A
- SMC N/A
- Revenue Next Year
- ATXS N/A
- SMC N/A
- P/E Ratio
- ATXS N/A
- SMC N/A
- Revenue Growth
- ATXS N/A
- SMC N/A
- 52 Week Low
- ATXS $3.56
- SMC $25.00
- 52 Week High
- ATXS $12.92
- SMC $45.89
- Technical
- Relative Strength Index (RSI)
- ATXS 38.86
- SMC 43.90
- Support Level
- ATXS $4.25
- SMC $26.49
- Resistance Level
- ATXS $5.47
- SMC $28.59
- Average True Range (ATR)
- ATXS 0.35
- SMC 1.52
- MACD
- ATXS 0.01
- SMC 0.27
- Stochastic Oscillator
- ATXS 27.45
- SMC 47.11
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About SMC SUMMIT MIDSTREAM CORPORATION
Summit Midstream Corp is a value-driven corporation focused on developing, owning and operating midstream energy infrastructure assets strategically located in unconventional resource basins, shale formations, in the continental U.S. It currently operates natural gas, crude oil and produced water gathering systems in four unconventional resource basins: the Williston Basin in North Dakota, which includes the Bakken and Three Forks shale formations; the Denver-Julesburg Basin, which includes the Niobrara and Codell shale formations in Colorado and Wyoming; the Fort Worth Basin in Texas, which includes the Barnett Shale formation; and the Piceance Basin in Colorado, which includes the liquids-rich Mesaverde formation as well as the emerging Mancos and Niobrara Shale formations.